Periscope Capital Inc. Ibere Pharmaceuticals Transaction History

Periscope Capital Inc.

  • $164 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$9.93 - $10.09 $141,254 - $143,530
14,225 Added 3.12%
470,395 $4.75 Million
Q3 2022

Nov 08, 2022
BUY
$0.11 - $9.94 $11,172 - $1.01 Million
101,570 Added 28.64%
456,170 $4.52 Million
Q1 2022

May 16, 2022
BUY
$9.69 - $9.81 $726,750 - $735,750
75,000 Added 26.82%
354,600 $3.48 Million
Q4 2021

Feb 14, 2022
BUY
$9.68 - $9.77 $2.42 Million - $2.44 Million
249,600 Added 832.0%
279,600 $2.71 Million
Q2 2021

Aug 13, 2021
BUY
$9.65 - $9.95 $289,500 - $298,500
30,000 New
30,000 $290,000

Others Institutions Holding IBER

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About IBERE PHARMACEUTICALS

IBER Quotes by TradingView
  • Ticker IBER
  • Exchange NYSE
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 13,800,000
  • Description
  • Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
More about IBER
Track This Portfolio

Track Periscope Capital Inc. Portfolio

Follow Periscope Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Periscope Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Periscope Capital Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email